Efficacy of Left Atrial Posterior Wall Isolation VS Left Atrial Posterior Wall isolation and Superior Vena Cava Isolation and Cavo-tricuspid isthmus Isolation and Mitral Isthmus Isolation for Recurrent Atrial Fibrillation Post Pulmonary Vein Isolation – A Randomised Control Trial

Alfred Hospital0 个研究点目标入组 264 人开始时间: 2024年5月28日最近更新: 2024年6月3日

适应症

试验速览

暂无简介。

•1.Patients aged greater than 18 years old
•2.Patients undergoing a second-time ablation procedure for AF
•3.Durable PVI found on second procedure.
•4.Persistent or paroxysmal AF - defined as a sustained episode lasting at least 7 days and less than three years (including or required chemical or electrical direct current cardioversion greater than 7 days post procedure)
•5.At least one episode of recurrent AF must have been documented by electrocardiogram (ECG), holter, loop recorder, telemetry, trans telephonic monitoring (TTM), or implantable device within last 6 months of enrolment in this investigation
•6.Patients must be able and willing to provide written informed consent to participate in this investigation; and
•7.Patients must be willing and able to comply with all peri-ablation and follow- up requirements.

•1.Patients with long-standing persistent AF - defined as a sustained episode lasting more than 3 years
•2.Patients for whom cardioversion or sinus rhythm will never be attempted/pursued
•3.Patients with AF felt to be secondary to an obvious reversible cause
•4.Patients with contraindications to systemic anticoagulation with heparin or coumadin or a direct thrombin inhibitor
•5.Pregnancy - will be assessed by patients informing the physicians
•6.End stage renal or hepatic failure.
•7.Severe valvular heart disease or cyanotic congenital heart disease.
•8.Diagnosis of hypertrophic cardiomyopathy.

发起方

Alfred Hospital